Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models (SBIR [R43/R44])

The summary for the Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models (SBIR [R43/R44]): There is a need to develop systems that are sensitive, selective, automated, and cost/size effective and capable of detection and identification of polymicrobial infections that may represent a threat to the survival of valuable biomedical animal resources or contribute confounding factors to research using these resources. This Funding Opportunity Announcement (FOA) seeks projects for rapid and sensitive detection of infectious agents as a key requirement for microbial identification in laboratory animal models. The diagnosis of polymicrobial infections has become increasingly important in enabling biological resource centers to meet the needs for establishing pathogen-free biological resources for current and future biomedical research needs. This funding opportunity announcement (FOA) encourages applications from small business concerns for Small Business Innovation Research (SBIR) projects that propose innovative research in the areas of detection and identification of infectious agents, including those involved in vertical transmission of diseases into embryos and larvae and development of required reagents and equipment. (See more information listed in Section I. Funding Opportunity Description).
Federal Grant Title: Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-11-340
Type of Funding: Grant
CFDA Numbers: 93.351
CFDA Descriptions: Research Infrastructure Programs
Current Application Deadline: Sep 07, 2014
Original Application Deadline: Sep 07, 2014
Posted Date: Sep 16, 2011
Creation Date: Feb 23, 2012
Archive Date: Oct 08, 2014
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related...
Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reprodu...
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Al...
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related...
Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of...
Shared Instrumentation Grant Program (S10)
Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research ...
More Grants from the National Institutes of Health
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/...
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com